Califf As Commissioner: Cardiologist, Trials Expert To Fill Top FDA Post
This article was originally published in Clinica
Executive Summary
Robert Califf became the first cardiologist to serve as commissioner of FDA with an 89-4 vote of support in the Senate Feb. 24.
You may also be interested in...
Califf Sets Departure From US FDA; Ostroff May Become Interim Leader
As FDA Commissioner Robert Califf prepares to step down from his post to make way for a Trump administration replacement, former Acting Commissioner Stephen Ostroff may step into the breach.
US WorldMeds’ Eflornithine Gets US FDA Panel Nod For Pediatric Neuroblastoma
In 14-6 vote, advisory committee said use of external control comparison to contextualize single-arm trial data demonstrated efficacy and reliance on preclinical data as confirmatory evidence was justified.
Veru Hopes To Position Enobosarm As Muscle-Protective In Weight-Loss Therapy
A selective androgen receptor modulator also being studied in metastatic breast cancer, enobosarm might offer potential as add-on therapy to GLP-1 agonists prescribed for weight loss, the Miami biotech asserts.